Evaluation of 2,3-dihydroimidazo[2,1-

Oxazoles / pharmacology Antitubercular Agents / pharmacology Structure-Activity Relationship
2,3-dihydroimidazo[2,1-b]oxazole anticancer antimicrobial delamanid imidazo[2,1-b]oxazole tuberculosis

Journal

Future medicinal chemistry
ISSN: 1756-8927
Titre abrégé: Future Med Chem
Pays: England
ID NLM: 101511162

Informations de publication

Date de publication:
10 2023
Historique:
medline: 7 11 2023
pubmed: 10 10 2023
entrez: 10 10 2023
Statut: ppublish

Résumé

Imidazo[2,1-

Identifiants

DOI: 10.4155/fmc-2023-0147 PMID: 37814826
pubmed: 37814826
doi: 10.4155/fmc-2023-0147
doi:

Substances chimiques

Oxazoles 0
Antitubercular Agents 0

Types de publication

Journal Article Review Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1885-1901

Auteurs

Afnan I Shahin (AI)

Research Institute for Medical and Health Sciences, University of Sharjah, Sharjah, 27272, United Arab Emirates.

Seyed-Omar Zaraei (SO)

Research Institute for Medical and Health Sciences, University of Sharjah, Sharjah, 27272, United Arab Emirates.
ORCID: 0000-0002-0212-2146

Shahed Alzuraiqi (S)

Department of Medicinal Chemistry, College of Pharmacy, University of Sharjah, Sharjah, 27272, United Arab Emirates.

Zahaa Abdulateef (Z)

Department of Medicinal Chemistry, College of Pharmacy, University of Sharjah, Sharjah, 27272, United Arab Emirates.

Noora E Abbas (NE)

Department of Medicinal Chemistry, College of Pharmacy, University of Sharjah, Sharjah, 27272, United Arab Emirates.

Taleb H Al-Tel (TH)

Research Institute for Medical and Health Sciences, University of Sharjah, Sharjah, 27272, United Arab Emirates.
Department of Medicinal Chemistry, College of Pharmacy, University of Sharjah, Sharjah, 27272, United Arab Emirates.

Mohammed I El-Gamal (MI)

Research Institute for Medical and Health Sciences, University of Sharjah, Sharjah, 27272, United Arab Emirates.
Department of Medicinal Chemistry, College of Pharmacy, University of Sharjah, Sharjah, 27272, United Arab Emirates.
Department of Medicinal Chemistry, Faculty of Pharmacy, Mansoura University, Mansoura, 35516, Egypt.
ORCID: 0000-0001-8587-0520

Articles similaires

Cost and cost-effectiveness of digital technologies for support of tuberculosis treatment adherence: a systematic review.

Cedric Kafie, Mona Salaheldin Mohamed, Miranda Zary et al.
1.00
Humans Cost-Benefit Analysis Tuberculosis Medication Adherence Digital Technology

The CRISPR-dCas9 interference system suppresses inhA gene expression in Mycobacterium smegmatis.

Nuntita Singpanomchai, Panan Ratthawongjirakul
1.00
Mycobacterium smegmatis Bacterial Proteins CRISPR-Cas Systems Gene Expression Regulation, Bacterial Oxidoreductases

Risk-stratified treatment for drug-susceptible pulmonary tuberculosis.

Vincent K Chang, Marjorie Z Imperial, Patrick P J Phillips et al.
1.00
Humans Rifampin Tuberculosis, Pulmonary Male Female

TamGen: drug design with target-aware molecule generation through a chemical language model.

Kehan Wu, Yingce Xia, Pan Deng et al.
1.00
Drug Design Models, Chemical Endopeptidase Clp Drug Discovery Humans

Classifications MeSH

questionsmedicales.fr › Composés hétérocycliques › Composés hétéromonocycliques › Azoles › Oxazoles › Evaluation of 2,3-dihydroimidazo[2,1-
questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Utilisations thérapeutiques › Anti-infectieux › Antibactériens › Antituberculeux › Evaluation of 2,3-dihydroimidazo[2,1-
questionsmedicales.fr › Phénomènes physiologiques › Phénomènes pharmacologiques et toxicologiques › Phénomènes pharmacologiques › Relation structure-activité › Evaluation of 2,3-dihydroimidazo[2,1-